Risk Factors for Red Blood Cell Transfusions in Children Undergoing Cardiac Catheterization

Ligon, R. Allen; Downey, Laura; Gruenewald, David L.; Bauser‐Heaton, Holly; Kim, Dennis W.; Roman, Meredith; Vincent, Robert; Petit, Christopher J.

doi:10.1016/j.jpeds.2019.10.033

Cited by 5 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients who required PRBC transfusion tended to be younger, lower weight, referred for catheterization from inpatient units, particularly the intensive care unit, had longer procedures with interventions performed, and use of larger diameter venous and arterial sheaths. The majority of transfusions occurred in patients less than 1 year of age (median 52 days) with single ventricle or complex biventricular physiology [4]. Based on this and reviewing our own institutional experience, we created new guidelines for when PRBC should be ordered and brought to catheterization lab for CCP (Table 1).…”

Section: Methodsmentioning

confidence: 99%

Using Quality Improvement to Optimize Blood Product Utilization in a Pediatric Cardiac Catheterization Laboratory

Trivedi,

Sheth,

Cooper

et al. 2023

Preprint

View full text Add to dashboard Cite

Packed red blood cells (PRBC) are frequently ordered for cardiac catheterization procedures, which increases resource utilization and patient charges. We created a quality improvement project focused on optimizing ordering of PRBC for pediatric cardiac procedures. Our primary aim was to increase adherence to ordering guidelines to greater than 97%, with a global aim to decrease patient cost by reducing associated charges. The existing blood product ordering guidelines were revised and procedure reports were updated to include administration of blood products. Appropriate measures were tracked to monitor the rate of pre-procedure PRBC orders, adherence to the new protocol guidelines, verify appropriate documentation and monitor the rate of blood transfusion within 24 hours post-procedure as well as incidence of emergency release blood during a procedure. During our study period, there was a statistically significant process change from a median of 86–100% adherence (p = 0.01) since implementation of the updated guidelines. With improved adherence, we decreased the use of hospital resources and charges to the patient in low-risk cardiac catheterization procedures, without an increase in adverse events.

show abstract

Section: Methodsmentioning

confidence: 99%

Using Quality Improvement to Optimize Blood Product Utilization in a Pediatric Cardiac Catheterization Laboratory

Trivedi,

Sheth,

Cooper

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Blood transfusions occur in approximately 21% of all operations, and in 45.8% of cardiac cases, however, they are associated with multiple risks and complications. Blood transfusion is also associated with immunomodulation, bacterial infection, and a multitude of non-infectious, but important, complications [ 5 , 6 , 7 ].…”

Section: Introductionmentioning

confidence: 99%

Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends

et al. 2022

View full text Add to dashboard Cite

Intraoperative haemostasis is of paramount importance in the practice of cardiovascular surgery. Over the past 70 years, topical haemostatic methods have advanced significantly and today we deal with various haemostatic agents with different properties and different mechanisms of action. The particularity of coagulation mechanisms after extracorporeal circulation, has encouraged the introduction of new types of topic agents to achieve haemostasis, where conventional methods prove their limits. These products have an important role in cardiac, as well as in vascular, surgery, mainly in major vascular procedures, like aortic dissections and aortic aneurysms. This article presents those agents used for topical application and the mechanism of haemostasis and offers general recommendations for their use in the operating room.

show abstract

Risk Factors for Adverse Events in Children with Pulmonary Hypertension Undergoing Cardiac Catheterization

et al. 2021

View full text Add to dashboard Cite

Risk Factors for Red Blood Cell Transfusions in Children Undergoing Cardiac Catheterization

Cited by 5 publications

References 27 publications

Using Quality Improvement to Optimize Blood Product Utilization in a Pediatric Cardiac Catheterization Laboratory

Using Quality Improvement to Optimize Blood Product Utilization in a Pediatric Cardiac Catheterization Laboratory

Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends

Risk Factors for Adverse Events in Children with Pulmonary Hypertension Undergoing Cardiac Catheterization

Contact Info

Product

Resources

About